FDA Inspection 1161191 — Apozeal Pharmaceuticals Inc.
The FDA completed an inspection of Apozeal Pharmaceuticals Inc. on Dec 15, 2021 in Levittown, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 15, 2021
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Levittown, PA (United States)